Literature DB >> 18710255

Computational model for predicting chemical substituent effects on passive drug permeability across parallel artificial membranes.

Chayan Acharya1, Paul R Seo, James E Polli, Alexander D Mackerell.   

Abstract

Drug permeability is often a limiting step in drug action, requiring chemical optimization of a drug candidate to improve this property. Such optimization is typically performed in the context of a congeneric series, where substituents are varied to optimize the target property. Motivated by this need the present work examines the influence of chemical substituents on passive permeability (log P pass) across parallel artificial membranes (PAMPA) undertaken for three congeneric series of compounds; benzoic acids, pyridines and quinolines. PAMPA showed pyridine and quinoline to have high permeability and chemical substituents to typically reduce the permeability. On the contrary, benzoic acid showed poor permeability and chemical substituents typically increased the permeability. To quantitate these effects with respect to physical properties, models were built to explain and predict the permeability of these classes of compounds based on computed molecular descriptors. Models for the benzoic acid series in the ionized state indicated the solvent accessible surface area, cavity dispersion and the free energy of solvation in hexane as well as in water to dominate permeability. However, when the acid group is treated as neutral, the free energy of solvation in water, the fraction polar surface area, the polar surface area and difference in the free energy of solvation between hexane and water were important; these terms, among others, were also important for the neutral pyridine-quinoline series. Considering that the permeability of the benzoic acid series is about 2 orders of magnitude lower than the pyridines and quinolines and that a shift of approximately two pH units in the p K a of the acid group of benzoic acid will allow for the neutral species of the molecule to dominate under experimental conditions (pH = 6.5), these results suggest that the additional energy barrier associated with permeation of the benzoic acid series is associated with the need to protonate the acidic group, thereby forming the neutral species which may then cross the hydrophobic region of the membrane.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18710255      PMCID: PMC2891763          DOI: 10.1021/mp800035h

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  24 in total

Review 1.  Virtual screening of intestinal drug permeability.

Authors:  P Stenberg; K Luthman; P Artursson
Journal:  J Control Release       Date:  2000-03-01       Impact factor: 9.776

2.  The in silico world of virtual libraries.

Authors: 
Journal:  Drug Discov Today       Date:  2000-08       Impact factor: 7.851

Review 3.  Prediction of intestinal permeability.

Authors:  William J Egan; Georgio Lauri
Journal:  Adv Drug Deliv Rev       Date:  2002-03-31       Impact factor: 15.470

4.  Protein kinases in drug discovery and development.

Authors:  Adrian Gill
Journal:  Drug Discov Today       Date:  2004-01-01       Impact factor: 7.851

5.  Novel factor Xa inhibitors based on a benzoic acid scaffold and incorporating a neutral P1 ligand.

Authors:  Marc Nazaré; Hans Matter; Otmar Klingler; Fahad Al-Obeidi; Herman Schreuder; Gerhard Zoller; Jörg Czech; Martin Lorenz; Angela Dudda; Anusch Peyman; Hans Peter Nestler; Matthias Urmann; Armin Bauer; Volker Laux; Volkmar Wehner; David W Will
Journal:  Bioorg Med Chem Lett       Date:  2004-06-07       Impact factor: 2.823

6.  Strong and weak hydrogen bonds in the protein-ligand interface.

Authors:  Sunil K Panigrahi; Gautam R Desiraju
Journal:  Proteins       Date:  2007-04-01

7.  Chemical substituent effect on pyridine permeability and mechanistic insight from computational molecular descriptors.

Authors:  I-Jen Chen; Rajneesh Taneja; Daxu Yin; Paul R Seo; David Young; Alexander D MacKerell; James E Polli
Journal:  Mol Pharm       Date:  2006 Nov-Dec       Impact factor: 4.939

8.  Continuum solvent model studies of the interactions of an anticonvulsant drug with a lipid bilayer.

Authors:  A Kessel; B Musafia; N Ben-Tal
Journal:  Biophys J       Date:  2001-06       Impact factor: 4.033

9.  Halogen bonds in biological molecules.

Authors:  Pascal Auffinger; Franklin A Hays; Eric Westhof; P Shing Ho
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-19       Impact factor: 11.205

10.  Permeation across hydrated DPPC lipid bilayers: simulation of the titrable amphiphilic drug valproic acid.

Authors:  Johan Ulander; A D J Haymet
Journal:  Biophys J       Date:  2003-12       Impact factor: 4.033

View more
  6 in total

1.  Molecular switch controlling the binding of anionic bile acid conjugates to human apical sodium-dependent bile acid transporter.

Authors:  Rana Rais; Chayan Acharya; Gasirat Tririya; Alexander D Mackerell; James E Polli
Journal:  J Med Chem       Date:  2010-06-24       Impact factor: 7.446

2.  Drug permeability prediction using PMF method.

Authors:  Fancui Meng; Weiren Xu
Journal:  J Mol Model       Date:  2012-10-27       Impact factor: 1.810

3.  Predicting and improving the membrane permeability of peptidic small molecules.

Authors:  Salma B Rafi; Brian R Hearn; Punitha Vedantham; Matthew P Jacobson; Adam R Renslo
Journal:  J Med Chem       Date:  2012-03-20       Impact factor: 7.446

4.  Structural determinants for transport across the intestinal bile acid transporter using C-24 bile acid conjugates.

Authors:  Rana Rais; Chayan Acharya; Alexander D Mackerell; James E Polli
Journal:  Mol Pharm       Date:  2010-11-01       Impact factor: 4.939

5.  Uptake, distribution and diffusivity of reactive fluorophores in cells: implications toward target identification.

Authors:  Christopher W Cunningham; Archana Mukhopadhyay; Gerald H Lushington; Brian S J Blagg; Thomas E Prisinzano; Jeffrey P Krise
Journal:  Mol Pharm       Date:  2010-08-02       Impact factor: 4.939

6.  Molecular dynamics simulations and experimental studies reveal differential permeability of withaferin-A and withanone across the model cell membrane.

Authors:  Renu Wadhwa; Neetu Singh Yadav; Shashank P Katiyar; Tomoko Yaguchi; Chohee Lee; Hyomin Ahn; Chae-Ok Yun; Sunil C Kaul; Durai Sundar
Journal:  Sci Rep       Date:  2021-01-27       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.